Navigation Links
NIH fellow uses computation, experimentation to study diabetes, obesity
Date:8/2/2011

221.10.254.64

Stephanie Nicole "Nikki" Lewis, a graduate student in the interdisciplinary doctoral program in genetics, bioinformatics, and computational biology at Virginia Tech, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award for Predoctoral Research through the National Institutes of Health for her study of a cellular signaling receptor that is associated with chronic inflammatory diseases such as diabetes, obesity, and inflammatory bowel disease.

Lewis is applying a combination of computational modeling and experimental methods to identify molecules that can activate peroxisome proliferator activated receptor gamma (PPAR ), which is a therapeutic target for suppressing inflammation. The search for drugs targeting the receptor is urgently needed since use of current drugs to treat type II diabetes by binding to PPAR , like the recently restricted Avandia (GlaxoSmithKline), results in adverse side effects. A goal of Lewis' research is to identify novel, orally active naturally occurring compounds with therapeutic potential due to their insulin-sensitizing and anti-inflammatory actions. The computational methods are used to quickly and inexpensively screen large numbers of compounds, from which a small number are selected for experimental validation in vitro and through pre-clinical animal studies.

This project entitled "Virtual Screening Development to Complement Experimental Screening for PPAR Modulators to Treat Type II Diabetes Mellitus" is primarily funded through the National Institute of Diabetes and Digestive and Kidney Diseases of NIH.

Lewis is working jointly with David Bevan, professor of biochemistry in the College of Agriculture and Life Sciences, and Josep Bassaganya-Riera, associate professor in the Nutritional Immunology and Molecular Medicine Laboratory at the Virginia Bioinformatics Institute (www.modelingimmunity.org).

"The strength of Nikki's research lies not only in the combination of computational and experimental methods, but also in her approach that will unravel details of the events that accompany PPAR  activation, thereby making the drug discovery process more rational," Bevan said.

"Nikki's successful NIH proposal builds upon ongoing collaborative research between Dr. Bevan and NIMML aimed at streamlining the drug and nutraceutical discovery process. In addition, Nikki's project leverages and extends the scope of studies conducted by the Center for Modeling Immunity to Enteric Pathogens. Specifically, this effort is in line with the goal of discovering novel broad-based immune therapeutics for gastrointestinal infectious diseases by creating computational models of the mucosal immune system and sets the stage for multi-scale modeling in drug discovery," Bassaganya-Riera said.


'/>"/>

Contact: Lori Greiner
lgreiner@vt.edu
540-231-5863
Virginia Tech
Source:Eurekalert  

Related biology news :

1. Green light for EU co-funding of TUM Institute for Advanced Study fellowships
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
3. Entomological Society of America names 2011 fellows
4. Weatherstone Fellows publish research as Autism Speaks announces 2011 Weatherstone Fellows
5. Top Latin-American scientists named 2011 Pew Fellows in the Biomedical Sciences
6. Rensselaer scholar receives NSF Research Fellowship
7. ASPB awards 15 summer undergraduate research fellowships
8. OGI awards summer research fellowships to 7 Ontario students
9. 5 UH graduates receive NSF fellowships for further study
10. Top Australian malaria researcher elected Fellow of the Royal Society
11. Fellowship to UC Riverside botanist encourages Hispanic students to take up research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH fellow uses computation, experimentation to study diabetes, obesity
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
Breaking Biology Technology: